This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Banks' capital requirements for exposure to crypto-assets consulted on by Basel Committee

( December 12, 2019, 10:48 GMT | Official Statement) -- Banks have been issued a consultation paper by the Basel Committee on Banking Supervision on their prudential treatment for exposure to crypto-assets. The paper asks for views on the design of higher capital and liquidity requirements for banks' exposures to virtual assets, with a potential different treatment for high-risk crypto-assets. The Basel Committee is also looking for views on the features and risks of the assets to inform a new prudential treatment for banks that are directly or indirectly exposed to virtual currencies. That includes multiple ways in which financial institutions are impacted by crypto-assets, including issuing them directly, or lending to individuals, corporates or financial institutions to allow them to invest in crypto-assets.Statement follows. Consultation attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login